Quick Answer
Quantum Biopharma Ltd. reported Research And Development Expense of $2.76 million for the year ending 2025.
- Quantum Biopharma Ltd. showed a decrease of -54.6% in Research And Development Expense from 2024 to 2025.
- This data is from Quantum Biopharma Ltd.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $2.76 million | Fiscal year 2024: $6.08 million | Fiscal year 2023: $3.86 million | Fiscal year 2022: $6.91 million | Fiscal year 2021: $6.33 million | Fiscal year 2020: $7.83 million | Fiscal year 2019: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: